Skip to main content
SpringerLink
Log in

Proteases and Alzheimer’s Disease: Present Knowledge and Emerging Concepts of Therapy

  • Chapter
Book cover Proteases In The Brain

Part of the book series: Proteases In Biology and Disease ((PBAD,volume 3))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  • Abraha A, Ghoshal N, Gamblin TC, Cryns V, Berry RW, Kuret J, Binder LI, 2000, C-terminal inhibiton of tau assembly in vitro and in Alzheimer’s disease. J Cell Sci 113: 3737–3745.

    CAS  PubMed  Google Scholar 

  • Allinson TM, Parkin ET, Turner AJ, Hooper NM, 2003, ADAMs family members as amyloid precursor protein alpha secretases. J Neurosci Res 74: 342–452.

    Article  CAS  PubMed  Google Scholar 

  • Alzheimer A, 1907. Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr 64: 146–148.

    Google Scholar 

  • Arendt T, 2003, Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the “Dr. Jekyll and Mr. Hyde concept” of Alzheimer’s disease or the yin and yang of neuroplasticity. Progr Neurobiol 71: 83–248.

    Article  PubMed  Google Scholar 

  • Banati RB, Rothe G, Valet G, Kreutzberg GW, 1993, Detection of lysosomal proteinases in microglia: flow cytometric measurement and histochemical localization of cathepsin B and L. Glia 7: 183–191.

    CAS  PubMed  Google Scholar 

  • Bendiske J, Bahr BA, 2003, Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis — an approach for slowing Alzheimer disease? J Neuropathol Exp Neurol 62: 451–463.

    CAS  PubMed  Google Scholar 

  • Bergman A, Religa D, Karlström H, Landon H, Winblad B, Lannfeldt L, Lundquist J, Näslund J, 2003, APP intracellular domain formation and unaltered signaling in the presence of familial Alzheimer’s disease mutations. Exp Cell Res 287: 1–9.

    Article  CAS  PubMed  Google Scholar 

  • Bernstein H-G, Bruszis S, Schmidt D, Wiederanders B, Dorn A, 1989, Immunodetection of cathepsin D in neuritic plaques found in brains of patients with Alzheimer’s disease. J Hirnforsch 30: 613–618.

    CAS  PubMed  Google Scholar 

  • Bernstein H-G, Wiederanders B, 1994, An immunohistochemical study of cathepsin E in Alzheimer-type dementia brains. Brain Res 667: 287–290.

    Article  CAS  PubMed  Google Scholar 

  • Bernstein H-G, Kirschke H, Wiederanders B, Schmidt D, Rinne A, 1990, Antigenic expression of cathepsin B in aged human brain. Brain Res Bull 24: 543–549.

    Article  CAS  PubMed  Google Scholar 

  • Bernstein H-G, Rinne R, Kirschke H, Järvinen M, Knöfel B, Rinne A, 1994, Cystatin-A like immunoreactivity is widely distributed in human brain and accumulates in neuritic plaques of Alzheimer disease subjects. Brain Res Bull 33: 477–481.

    Article  CAS  PubMed  Google Scholar 

  • Bernstein H-G, Kirschke H, Wiederanders B, Pollak K-H, Zipress A, Rinne A, 1996, The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease. Mol Chem Neuropathol 27: 225–247.

    CAS  PubMed  Google Scholar 

  • Bernstein H-G, Ansorge S, Riederer P, Reiser M, Frölich L, Bogerts B, 1999, Insulin-degrading enzyme in the Alzheimer’s disease brain: prominent localization in neurons and senile plaques. Neurosci Lett 263: 161–164.

    Article  CAS  PubMed  Google Scholar 

  • Bernstein H-G, Bukowska A, Krell D, Bogerts B, Ansorge S, Lendeckel U, 2003, Comparative localization of ADAMs 10 and 15 in human cerebral cortex: normal aging, Alzheimer disease and Down syndrome. J Neurocytol 32: 153–160.

    Article  CAS  PubMed  Google Scholar 

  • Beyreuther K, Masters CL, 1990, Nomenclature of amyloid A4-proteins and their precursors in Alzheimer’s disease and Down’s syndrome. Neurobiol Aging 11: 66–68.

    CAS  PubMed  Google Scholar 

  • Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RCP, Perry R, Watson B, Bassett SS, McInnis MG, Albert MS, Hyman BT, Tanzi RE, 1998, Alpha-2-macro-globulin is genetically associated with Alzheimer disease. Nature Genetics 19: 357–360.

    CAS  PubMed  Google Scholar 

  • Bohne S, Kletten K, Menard R, Buhling F, Vockler S, Wrenger E, Roessner A, Röcken C, 2004, Cleavage of A1 amyloid protein and Al amyloid deposits by cathepsins B, K and L. J Pathol 203: 528–537.

    Article  CAS  PubMed  Google Scholar 

  • Braak H, Braak E, 1996, Evolution of the neuropathology of Alzheimer’s disease. Acta Neural Scand. Suppl. 165: 3–12.

    CAS  Google Scholar 

  • Braunewell K-H, Riederer P, Spilker C, Gundelfinger ED, Bogerts B, Bernstein H-G, 2001, Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (VILIPs)-1 and-3, in neocortical brain areas of Alzheimer disease patients. Dement Geriatr Cogn Disord 12: 110–116.

    Article  CAS  PubMed  Google Scholar 

  • Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC, 2001, BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4: 233–234.

    Article  CAS  PubMed  Google Scholar 

  • Caille II, Allinquant B, Dupont E, Bouillot C, Langer A, Muller UP, 2004, Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricularzone. Development 131: 2173–2181.

    Article  CAS  PubMed  Google Scholar 

  • Carson JA, Turner AJ, 2002, β-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J Neurochem 81: 1–8.

    Article  CAS  PubMed  Google Scholar 

  • Cataldo AM, Nixon RA, 1990, Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer disease. Proc Natl AcadSci 87: 3861–3865.

    CAS  Google Scholar 

  • Citron M, 2002, Emerging Alzheimer’s disease therapies: inhibition of β-secretase. Neurobiol Aging 23: 1017–1022.

    Article  CAS  PubMed  Google Scholar 

  • Clarimon J, Munoz EJ, Boada M, Tarraga L, Sunyer J, Bertranpetit J, Comas D, 2003, Possible increased risk for Alzheimer’s disease associated with neprilysin gene. J Neural Transm 110: 651–657.

    CAS  PubMed  Google Scholar 

  • Colciaghi F, Marcello E, Borroni B, Zimmermann M, Caltagirone C, Cattabeni F, Padovani A, Di Luca M, 2004, Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease. Neurology 62: 498–501.

    CAS  PubMed  Google Scholar 

  • Cook DG, Leverenz JB, McKillan PJ, Kulstadt JJ, Ericksen S, Roth RA, Schellenberg GD, Jin LW, Kovacina KS, Craft S, 2003, Reduced hippocampal insulin degrading enzyme in late onset Alzheimer’s disease is associated with the apolipoprotein E-ε4 type. Am J Pathol 162: 3131–319.

    Google Scholar 

  • Craft S, Watson SG, 2004, Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3: 169–178.

    CAS  PubMed  Google Scholar 

  • De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F, 1998, Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor. Nature 391: 387–390.

    PubMed  Google Scholar 

  • Dickson DW, 2004, Building a more perfect beast. APP transgenic mice with neuronal loss. Am J Pathol 164: 1143–1146.

    PubMed  Google Scholar 

  • Ding Q, Keller JN, 2003, Does proteasome inhibition play a role in mediating neropathology and neuron death in Alzheimer’s disease? J Alzheimers Dis 5: 241–245.

    CAS  PubMed  Google Scholar 

  • Dorn A, Bernstein H-G, Rinne A, Ziegler M, Hahn H-J, Ansorge S, 1983, Insulin-and glucagon-like peptides in the brain. Anat Rec 207: 69–77.

    Article  CAS  PubMed  Google Scholar 

  • Dorn A, Bernstein H-G, Reiser M, Rinne A, Ansorge S, 1986, Degradation of insulin and glucagon in developing kidney: immunolocalization of insulin-glucagon specific protease and quantitative estimation. J Histochem Cytochem 34: 411–412.

    CAS  PubMed  Google Scholar 

  • Dovey HF, John V, Anderson JP, Chen LZ, de Saint Andrieu P, Fang LY, Freedman SB, Folmer B, Goldbach E, Holsztynska EJ, Hu KL, Johnson-Wood KL, Kennedy SL, Kholodenko D, Knops JE, Latimer LH, Lee M, Liao Z, Lieberburg IM, Motter RN, Mutter LC, Nietz J, Quinn KP, Sacchi KL, Seubert PA, Shopp GM, Thorsett ED, Tung JS, Wu J, Yang S, Yin CT, Schenk DB, May PC, Altstiel L, Bender MH, Boggs LN, Britton TC, Clemens JC, Czilli DL, Dieckman-McGinty DK, Droste JJ, Fuson KS, Gitter BD, Hyslop PA, Johnstone EM, Li WY, Little SP, Mabry TE, Miller FD, Audia JE, 2001, Functional gamma-secretase inhibitors beta-amyloid peptide levels In brain. J Neurochem 76: 173–181.

    Article  CAS  PubMed  Google Scholar 

  • Ertekin-Taner N, Allen M, Fadale D, Scanlin L, Younkin L, Petersen T, Graff-Radford N, Younkin SG, 2004, Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease. Hum Mutat 23: 334–342.

    Article  CAS  PubMed  Google Scholar 

  • Esler WP, Wolfe MS, 2001, A portrait of Alzheimer secretases — new features and familiar faces. Science 239: 1449–1454.

    Google Scholar 

  • Farris W, Mansourian S, Leissring MA, Eckman WA, Bertram L, Eckman CB, Tanzi RE, Selkoe DJ, 2004, Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 164: 1425–1435.

    CAS  PubMed  Google Scholar 

  • Farzan M, Schnitzler CE, Vasilieva N, Leung D, Choe H, 2000, BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the of the amyloidbeta precursor protein. Proc Natl Acad Sci USA 97: 9712–9717.

    Article  CAS  PubMed  Google Scholar 

  • Ferrer I, Boada Rovira M, Sanchez Guerra ML, Rey MJ, Costa-Juss P, 2004, Neuropathology and pathogenesis of encephalitis follwing amyloid-beta immunization in Alzheimer’s disease. Brain Pathol 14: 11–20.

    CAS  PubMed  Google Scholar 

  • Fischer DF, De Vos RAI, Van Dijk R, De Vrij FMS, Proper EA, Sonnemans MAC, Verhage MC, Sluijs JA, Hobo B, Zouambia M, Jansen Steur ENH, Kamphorst W, Hol FW, 2003, Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J 17: 2014–2024.

    Article  CAS  PubMed  Google Scholar 

  • Frölich L, Blum-Degen D, Bernstein H-G, Engelsberger S, Humrich J, Laufer A, Thalheimer A, Türk A, Hoyer S, Zöchling R, Boissl KW, Jellinger K, Riederer P, 1998, Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease. J Neural Transm 105: 423–438.

    PubMed  Google Scholar 

  • Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL, 2003, Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer’s disease. Proc Natl Acad Sci USA 100: 10032–10037.

    Article  CAS  PubMed  Google Scholar 

  • Gan L, Ye S, Chu A, Anton K, Yi S, Vincent VA, von Schack D, Chin D, Murray J, Lohr S, Patthy L, Gonzalez-Zulueta M, Nikolich K, Urfer R, 2004, Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using functional genomics approach. J Biol Chem 279: 5565–5572.

    Article  CAS  PubMed  Google Scholar 

  • Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder, 1985, Abnormal phosphorylation of the microtubule-associated protein in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83: 4913–4917.

    Google Scholar 

  • Grynspan F, Griffin A, Cataldo A, Katayama S, Nixon RA, 1997, Active-site directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer’s disease. Brain Res 763: 145–158.

    Article  CAS  PubMed  Google Scholar 

  • Haass C, 2004, Take five-BACE and the y-secretase quartet conduct Alzheimer’s amyloid β-peptide geneneration. EMBO Journal 23: 483–488.

    Article  CAS  PubMed  Google Scholar 

  • Hamel RG, Bennett RG, Duckworth WC, 1998, Regulation of multicatalytic enzyme activity by insulin and insulin-degrading enzyme. Endocrinology 129: 4061–4066.

    Google Scholar 

  • Harding AJ, Kril JJ, Halliday C, 2000, Practical measures to simplify the Braak stain method for routine pathological screening. Acta Neuropathol 99: 199–208.

    CAS  PubMed  Google Scholar 

  • Hardy J, Selkoe DJ, 2002, The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutic. Science 297: 353–356.

    Article  CAS  PubMed  Google Scholar 

  • Hartmann D, Toumoy J, Saftig P, Annaert A, De Strooper B, 2001, Implications of APP secretases in notch signaling. J Mol Neurosci 17: 171–181.

    CAS  PubMed  Google Scholar 

  • Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP, 2002, Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer’s disease. J Neurochem 83: 509–524.

    Article  Google Scholar 

  • Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B, 2000, Total inactivation of y-secretase in presenilin-deficient embryonic stem cells. Nat Cell Biol 2: 461–462.

    CAS  PubMed  Google Scholar 

  • Honer WG, 2003, Pathology of presynaptic proteins in Alzheimer’s disease: more than simple loss of terminals. Neurobiol Aging 24: 1047–1062.

    Article  CAS  PubMed  Google Scholar 

  • Hook VY, Reisine TD, 2003, Cysteine proteases are the major beta-secretase in the regulatory secretory pathway that provides most of the beta-amyloid in Alzheimer’s disease: role of BACE1 in the constitutive secretory pathway. J Neurosci Res 74: 393–405.

    Article  CAS  PubMed  Google Scholar 

  • Hooper NM, Turner AJ, 2002, The search for α-secretase and its potential as a therapeutic approach to Alzheimer’s disease. Current Med Chem 9: 1107–1119.

    CAS  Google Scholar 

  • Hoyer S, 1998, Is sporadic Alzheimer disease the type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105: 415–422.

    Article  CAS  PubMed  Google Scholar 

  • Hoyer S, 2004, Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490: 115–125.

    Article  CAS  PubMed  Google Scholar 

  • Hyman BT, Gomez-Isla T, 1996, Neuropathological markers of impaitred cognition in the entorhinal cortex. Neurobiol Aging 17: 940–941.

    Article  CAS  PubMed  Google Scholar 

  • Iwata MH, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC, 2001, Metabolic regulation of brain Aβ by neprilysin. Science 292: 1550–1552.

    Article  CAS  PubMed  Google Scholar 

  • Iwata N, Mizukami H, Shirotani K, Takaki Y, Muramatsu S, Lu B, Gerard NP, Gerard C, Ozawa K, Saido T C, 2004, Presynaptic localization contributes to efficient clearance of amyloid-beta peptide in mouse brain. J Neurosci 24: 991–998.

    CAS  PubMed  Google Scholar 

  • Iwata N, Takaki Y, Fukami S, Tsubuki S, Saido TC, 2002, Region-specific reduction of Abeta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J Neurosci Res 70: 493–500.

    Article  CAS  PubMed  Google Scholar 

  • Karkainen I, Rybnikova E, Pelto-Huikko M, Huovila AP, 2000, Metalloprotease-integrin (ADAM) genes are widely distributed and differently expressed in the adult CNS. Mol Cell Neurosci 15: 547–565.

    Google Scholar 

  • Keck S, Nitsch R, Grune T, Ullrich O, 2003, Proteasome inhition by paired helical filament—tau in brains of patients with Alzheimer’s disease. J Neurochem 85: 115–122.

    CAS  PubMed  Google Scholar 

  • Kim TW, Tanzi RE, 1997, Presenilins and Alzheimer’s diease. Curr Opin Neurobiol 7: 683–688.

    Article  CAS  PubMed  Google Scholar 

  • Kingham PJ, Pocock JM, 2001, Micoglial apoptosis induced by chromogranin A is mediated by mitochondrial depolarization and the permeability transition but not by cytochrome release. J Neurochem 74: 1452–1462.

    Google Scholar 

  • Kirschling CM, Koisch H, Frahnert C, Rao ML, Maier W, Heun R, 2003, Polymorphism in the BACE gene influences the risk for Alzheimer’s disease. Neuroreport 14: 1243–1246.

    CAS  PubMed  Google Scholar 

  • Koike H, Tomioka S, Sorimachi H, Saido T, Muruyama K, Okuyama A, Fujisara-Sehara A, Ohno S, Suzuki K, Ishiura S, 1999, Membrane anchored metalloprotease MDC 9 has an alpha-secretase activity responsible for processing of the amyloid precursor. Biochem J 343: 371–345.

    Article  CAS  PubMed  Google Scholar 

  • Kurochkin IV, 1998, Amyloidogenic determinant as a substrate recognition site motif of insulin degrading enzyme. FEBS Lett 427: 153–156.

    Article  CAS  PubMed  Google Scholar 

  • Kurochkin IV, Goto S, 1994, Alzheimer’s beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345: 33–37.

    Article  CAS  PubMed  Google Scholar 

  • Lammich S, Koiro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F, 1999, Constitutive and regulated α-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 96: 3922–3927.

    Article  CAS  PubMed  Google Scholar 

  • LeBlanc A, Liu H, Goodyer C, Bergeron C, Hammond J, 1999, Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer’s disease. J Biol Chem 274: 23426–23436.

    CAS  PubMed  Google Scholar 

  • Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun Y, Frosch MP, Selkoe DJ, 2003, Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation secondary pathology, and premature death. Neuron 40: 1087–1093.

    Article  CAS  PubMed  Google Scholar 

  • Lewis HD, Perez Revuelta BI, Nadin A, Neduvelil JG, Harrison T, Pollack SJ, Shearman MS, 2003, Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and APP cleavages. Biochemistry 42: 7580–7586.

    CAS  PubMed  Google Scholar 

  • Li Y, Wang H, Wang S, Quon D, Liu YW, Cordell B, 2003, Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc Natl Acad Sci USA 100: 259–264.

    CAS  PubMed  Google Scholar 

  • Litersky J M, Johnson G V, 1995, Phosphorylation of tau in vitro: inhibition of calcium-dependent proteolysis. J Neurochem 65: 903–911.

    CAS  PubMed  Google Scholar 

  • Lopez-Perez E, Zhang Y, Frank SJ, Creemers J, Seidah N, Checler F, 2001, Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin-metalloprotease ADAM10. J Neurochem 76: 1532–1539.

    Article  CAS  PubMed  Google Scholar 

  • Lue L-F, Kuo AE, Roher L, Brachova Y, Shen L, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J, 1999, Soluble amyloid β-peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am J Pathol 155: 853–862.

    CAS  PubMed  Google Scholar 

  • Marcinkiewicz M, Seidah NG, 2000, Coordinated expression of beta-amyloid precursor protein and the putative β-secretase and α-secretase ADAM 10 in mouse and human brain. J Neurochem 75: 2133–2143.

    Article  CAS  PubMed  Google Scholar 

  • Marlow L, Cain M, Pappolla MA, Sambamurti K, 2002, Beta-secretase processing of the Alzheimer’s amyloid protein precursor (APP). J Mol Neurosci 20: 233–139.

    Google Scholar 

  • Masliah E, Terry RD, 1993, Role of synaptic pathology in the mechanism of dementia in Alzheimer’s disease. Clin Neurosci 1: 192–198.

    Google Scholar 

  • Masliah E, Alford R, De Teresa M, Mallory M, Hansen L, 1996, Deficient glutamate transport is associated with neurodegeneration in Alzheimer’s disease. Ann Neurol 40: 759–766.

    Article  CAS  PubMed  Google Scholar 

  • McDermott JR, Gibson AM, 1997, Degradation of Alzheimer’s beta amyloid protein by human and rat peptidases: involvement of insulin-degrading enzyme. Neurochem Res 22: 49–56.

    Article  CAS  PubMed  Google Scholar 

  • McGeer PL, Itagaki H, Tago H, McGeer EG, 1987, Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79: 195–200.

    Article  CAS  PubMed  Google Scholar 

  • McGeer PL, McGeer EG, 1995, The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21: 195–218.

    Article  CAS  PubMed  Google Scholar 

  • McGeer PL, McGeer EG, 2001, Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22: 799–809.

    CAS  PubMed  Google Scholar 

  • Mehmet H, 2000, Caspases find a new place to hide. Nature 403: 29–30.

    Article  CAS  PubMed  Google Scholar 

  • Mohajeri MH, Wollmer MA, Nitsch RM, 2002, Abeta-42 induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo. J Biol Chem 277: 35460–35465.

    CAS  PubMed  Google Scholar 

  • Mohajeri MH, Kuehnle K, Li H, Poirier R, Tracy J, Nitsch RM, 2004, Anti-amyloid activity of neprilysin in plaque-bearing mouse models of AD. FEBS Lett 562: 16–21.

    Article  CAS  PubMed  Google Scholar 

  • Nakanishi H, Tominaga K, Amano T, Hirotsu I, Inoue T, Yamamoto K, 1994, Age-related changes in activities and localizations of cathepsins D, E, B and L in rat brain tissues. Exp Neurol 125: 1–10.

    Google Scholar 

  • Nakanishi H, 2003, Neuronal and microglial cathepsins in aging and age-related diseases. Ageing Res Rev 2: 367–381.

    CAS  PubMed  Google Scholar 

  • Neve RL, 2003, A new wrestler in the battle between α-and-β-secretases for cleavage of APP. Trends Neurosci 26: 461–463.

    Article  CAS  PubMed  Google Scholar 

  • Nishioku T, Hashimoto K, Yamashita K, Liou S-Y, Katsunuma N, Peters C, von Figura K, Saftig P, Yamamoto K, Nakanishi H, 2002, Involvement in exogenous antigen processing in primary cultured murine microglia. J Biol Chem 277: 4816–4822.

    Article  CAS  PubMed  Google Scholar 

  • Nixon RA, 2001, A “protease activation cascade” in the pathogenesis of Alzheimer’s Disease. Ann N Y Acad Sci 924: 17–131.

    Google Scholar 

  • Ntais C, Polycarpou A, loannidis JP, 2004, Meta-analysis of the association of the cathepsin D Ala224Va gene polymorphism with the risk of Alzheimer’s disease: a HuGE gene-disease association review. Am J Epidemiol 159: 527–536.

    Article  PubMed  Google Scholar 

  • Okomato K, Hirai S, lizuka T, Yanagisawa T, Watanabe M, 1991, Reexamination of granulovacuolar degeneration. Acta Neuropathol 82: 340–345.

    Google Scholar 

  • Ott A, Stolk RP, van Harskamp F, Pols HA, Hofmann A, Breteler MM, 1999, Diabetes mellitus and the risk of Alzheimer: The Rotterdam Study. Neurology 53: 1937–1342.

    CAS  PubMed  Google Scholar 

  • Park IH, Jeon SY, Lee HJ, Song K.S, 2004, A beta-secretase (BACE1) inhibitor hispidin from the mycelial cultures of Phellinus linteus. Planta Med 70: 143–146.

    Article  CAS  PubMed  Google Scholar 

  • Pasternak SH, Callahan JW, Mahuran DJ, 2004, The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer disease: re-examining the spatial paradox from the lysosomal perspective. J Alzheimers Dis 6: 53–56.

    CAS  PubMed  Google Scholar 

  • Petanceska S, Petanceska P, Canoll P, Levi AL, 1996, Expression of rat cathepsin S in phagocytic cells. J Biol Chem 271: 4403–4409.

    CAS  PubMed  Google Scholar 

  • Perez A, Morelli L, Cresto JC, Castano EM, 2000, Degradation of soluble amyloid β-peptides 1-40, 1-42 and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brain. Neurochem Res 25: 247–255.

    CAS  PubMed  Google Scholar 

  • Qui WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, A, Safavi A, Hersh LB, Selkoe DJ, 1998, Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273: 32730–32738.

    Google Scholar 

  • Rangan SK, Liu R, Brune D, Planque S, Paul S, Sierks MR, 2003, Degradation of beta-amyloid by proteolytic antibody light chains. Biochemistry 42: 14328–14334.

    Article  CAS  PubMed  Google Scholar 

  • Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A, 2002, Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci USA 99: 6364–6369.

    Article  CAS  PubMed  Google Scholar 

  • Reiser G, Bernstein H-G, 2004, Altered expression of protein p42IP4/centaurin-alpha1 in Alzheimer’s disease brains and possible interaction of p42IP4 with nucleolin. Neuroreport 19: 147–148.

    Google Scholar 

  • Reiser M, Bernstein H-G, Ansorge S, Dorn A, 1987, Proteolytic degradation of insulin and glucagon in rat brain during ontogenesis. Acta histochem. 82: 35–39.

    CAS  PubMed  Google Scholar 

  • Rogers J, Luber-Narod J, Sturen CD, Civin WH, 1988, Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer’s disease. Neurobiol Aging 9: 339–349.

    CAS  PubMed  Google Scholar 

  • Roggo S, 2002, Inhibiton og BACE, a promising approach to Alzheimer’s disease therapy. Curr Top Med Chem 2: 359–370.

    Article  CAS  PubMed  Google Scholar 

  • Safavi A, Miller BC, Cottam L, Hersh LB, 1996, Identification of gamma-endorphin-degrading enzyme as insulin-degrading enzyme. Biochemistry 35: 14318–14325.

    Article  CAS  PubMed  Google Scholar 

  • Samuels C, Grossman H, 2003, Emerging therapeutics for Alzheimer’s disease: an avenue of Hope. CNS Spectr 8: 834–845.

    PubMed  Google Scholar 

  • Saric T, Müller D, Seitz H-J, Pavelic K, 2003, Non-convalent interaction of ubiquitin with insulin-degrading enzyme. Mol Cell Endocrinol 204: 11–20.

    Article  CAS  PubMed  Google Scholar 

  • Sato M, Ikeda K, Haga S, Allsop D, Ishii T, 1991, A monoclonal antibody to common acute lymphoblastic leukaemia antigen (neutral endopeptidase) immunostains senile plaques in the brains with Alzheimer’s disease. Neurosci Lett 121: 271–273.

    Article  CAS  PubMed  Google Scholar 

  • Selkoe DJ, 1994, Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 17:489–517.

    Article  CAS  PubMed  Google Scholar 

  • Selkoe DJ, 2001, Presenilin, Notch and the genesis and treatment of Alzheimer’s disease. Proc Natl Acad Sci USA 98: 11039–11041.

    Article  CAS  PubMed  Google Scholar 

  • Sennvik K, Bogdanovic N, Volkmann I, Fastboom J, Benedikz E, 2004, Beta-secretase-cleaved amyloid precursor protein in Alzheimer brain: a morphologic study. J Cell Mol Med 8: 127–134.

    CAS  PubMed  Google Scholar 

  • Sherrington R, Rogaev EL, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi AP, Sorbi S, Rainero I, Pinessi, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky R J, Wasco W, Dasilva HAR, Haines JL, Pericakvance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St.George-Hyslop PH, 1995, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375: 754–760.

    Article  CAS  PubMed  Google Scholar 

  • Sisodia SS, St. George-Hyslop PH, 2002, Gamma-secretase, Notch, and Alzheimer’s disease: where do the presenilins fit in? Nat Rev Neurosci 3: 281–290.

    Article  CAS  PubMed  Google Scholar 

  • Skovronsky DM, Moore DB, Milla ME, Doms RW, Lee VM, 2000, Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid precursor protein in the trans-Golgi network. J Biol Chem 275:2568–2575.

    Article  CAS  PubMed  Google Scholar 

  • Su JH, Kesslak P, Head E, Cotman CW, 2002, Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovascuolar degeneration in Alzheimer’s disease and Down’s syndrome brain. Acta Neuropathol 104: 1–6.

    Article  CAS  PubMed  Google Scholar 

  • Takuma H, Tomiyama T, Kuida K, Mori H, 2004, Amyloid beta peptide-induced neuronal loss is mediated by caspase-3 in vivo. J Neuropathol Exp Neurol 63: 255–261.

    CAS  PubMed  Google Scholar 

  • Takuma K, Baba A, Matsuda T, 2004, Astrocyte apoptosis: implications for neuroprotection. Progr Neurobiol 72: 111–127.

    Article  CAS  PubMed  Google Scholar 

  • Tanzi RE, McClatchey AI, Lampert ED, Villa-Komaroff L, Gusella JL, Neve RL, 1988, Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease. Nature 331: 528–530.

    Article  CAS  PubMed  Google Scholar 

  • Van Leeuwen FW, De Kleijn DPV, Van den Hurk WH, Neubauer A, Sonnmans MAF, Sluijs JA, Köycü S, Ramdjielal RDJ, Salehi A, Martens SJ, 1998, Frameshift mutants of β-amyloid precursor protein and ubiquitin-B in Alzheimer’s and Down patients. Science 279: 242–247.

    PubMed  Google Scholar 

  • Vassar R, 2001, BACE. A prime target for Alzheimer’s disease. J Mol Neurosci 17: 157–170.

    CAS  PubMed  Google Scholar 

  • Waters SM, David TP, 1995, Alterations of substance P metabolism and neuropeptidases in Alzheimer’s disease. J Gerontol A Biol Sci Med Sci 50: B315–319.

    CAS  PubMed  Google Scholar 

  • Vassar R, 2002, β-secretase (BACE) as drug target for Alzheimer’s disease. Adv Drug Deliv Rev 54: 1589–1602.

    Article  CAS  PubMed  Google Scholar 

  • Vassar R, 2004, BACE 1. The beta-secretase enzyme in Alzheimer’s disease. J Mol Neurosci 23: 105–114.

    CAS  PubMed  Google Scholar 

  • Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR, Selkoe DJ, 2000, Neurons regulate extracellular levels of amyloid beta-protein proteolysis by insulin-degrading enzyme. J Neurosci 20: 1657–1665.

    CAS  PubMed  Google Scholar 

  • Weber SJ, Louis RB, Trombley L, Bissette G, Davies P, Davis TP, 1992, Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer’s disease. J Gerontol 47: B18–25.

    CAS  PubMed  Google Scholar 

  • Wolfsberg T, Primakoff P, Myles DG, White JM, 1995, ADAM, a novel family of membrane-proteins containing a disintegrin and metalloprotease domain-Multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol 131: 275–278.

    Article  CAS  PubMed  Google Scholar 

  • Yang Y, Mufson EJ, Herrup K, 2003, Neuronal cell death by cell cycle events at all stages of Alzheimer’s disease. J Neurosci 23: 2557–2563.

    CAS  PubMed  Google Scholar 

  • Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, Song YQ, Rogaeva E, Chen F, Kawarai T, Supala A, Levesque L, Yu H, Yang DS, Holmes E, Milman P, Liang Y, Zhang DM, Xu DH, Sato C, Rogaev E, Smith M, Janus C, Zhang Y, Aebersold R, Farrer LS, Sorbi S, Bruni A, Fraser P, St George-Hyslop P, 2000, Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing. Nature 407: 48–54.

    CAS  PubMed  Google Scholar 

  • Zlokovic BV, 2004, Clearing amyloid through the blood-brain barrier. J Neurochem 89: 807–811.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University Hospital Magdeburg, Leipziger Str.44, D-39120, Magdeburg, Germany

    Hans-Gert Bernstein

Authors
  1. Hans-Gert Bernstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Otto-von-Guericke University, Magdeburg, Germany

    Uwe Lendeckel

  2. University of Leeds, Leeds, UK

    Nigel M. Hooper

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science + Business Media, Inc. Dordrecht

About this chapter

Cite this chapter

Bernstein, HG. (2005). Proteases and Alzheimer’s Disease: Present Knowledge and Emerging Concepts of Therapy. In: Lendeckel, U., Hooper, N.M. (eds) Proteases In The Brain. Proteases In Biology and Disease, vol 3. Springer, Boston, MA. https://doi.org/10.1007/0-387-23101-3_1

Download citation

Publish with us

Policies and ethics

Search

Navigation